No Data
No Data
Express News | University of Nebraska Medical Center To Enroll Patients For RenovoRx's Phase III TIGeR-PaC Clinical Trial
Express News | University of Nebraska Medical Center Launches Patient Enrollment for Renovorx’s Pivotal Phase III Tiger-Pac Clinical Trial
RenovoRx Initiated at Buy by Ascendiant Capital
RenovoRx Initiated at Buy by Ascendiant Capital
RenovoRx Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/17/2024 620.72% Ascendiant Capital → $8 Initiates Coverage On → Buy 02/02/2024 260.36% Alliance Global
Ascendiant Initiates RenovoRx(RNXT.US) With Buy Rating, Announces Target Price $8
Ascendiant analyst Edward Woo initiates coverage on $RenovoRx(RNXT.US)$ with a buy rating, and sets the target price at $8.According to TipRanks data, the analyst has a success rate of 0.0% and a tota
Express News | RenovoRx Inc : Ascendiant Capital Markets Initiates With Buy Rating; Price Target $8
No Data